These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6806643)

  • 1. The effect of testosterone treatment on the ability of female rat liver S9 to activate aflatoxin B1 and 2-aminofluorene in the AMES/Salmonella system.
    Chernesky P; Jayaraj A; Richardson A
    Mutat Res; 1982 Mar; 103(3-6):267-73. PubMed ID: 6806643
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic dependence of hepatic microsome-mediated depression of aflatoxin B1 activation to mutagens in Ames Salmonella typhimurium TA-98 system.
    Raina V; Gurtoo HL; Berrigan M; Paigen B
    Biochem Biophys Res Commun; 1980 Jun; 94(3):737-43. PubMed ID: 6772179
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of aflatoxin B1 mutagenesis: addition of glutathione and glutathione-S-transferase to the Salmonella mutagenicity assay.
    Jorgensen KV; Clayton JW; Price RL
    Environ Mutagen; 1987; 9(4):411-9. PubMed ID: 3107976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
    Uwaifo AO; Bababunmi EA
    Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems.
    Beaune P; Lemestré-Cornet R; Kremers P; Albert A; Gielen J
    Mutat Res; 1985 Jun; 156(3):139-46. PubMed ID: 3889631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosol is required for the modulation by dietary casein of the hepatic microsomal activation of aflatoxin B1 to mutagenic metabolites detectable in Salmonella.
    Woodall GM; Dauterman WC; Hagler WM; DeMarini DM
    Mutagenesis; 1999 Jul; 14(4):365-73. PubMed ID: 10390503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species-dependent effects of dietary lindane and/or zineb on the activation of aflatoxin B1 into mutagenic derivatives.
    Decloitre F; Hamon G
    Mutat Res; 1980 Nov; 79(3):185-92. PubMed ID: 6163982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
    Jayaraj A; Hardwick JP; Diller TW; Richardson AG
    J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
    Pavlov IuI; Khromov-Borisov NN
    Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutagenicity of 2-nitrofluoranthene and its in vitro hepatic metabolites.
    Zielinska B; Harger WP; Arey J; Winer AM; Haas RA; Hanson CV
    Mutat Res; 1987 Apr; 190(4):259-66. PubMed ID: 3550452
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the mutagenic effect of a medium containing aflatoxin B1 as a result of the yeast activity].
    Borisenko AE; Mirskaia EE; Borisenko EG
    Gig Sanit; 1990 Dec; (12):45-7. PubMed ID: 2128746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of aflatoxin B1 by using the synergistic effect of hydrogen peroxide and gamma radiation.
    Patel UD; Govindarajan P; Dave PJ
    Appl Environ Microbiol; 1989 Feb; 55(2):465-7. PubMed ID: 2497710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
    Lake BG; Rowland IR; Harris RA; Collins MA; Phillips JC; Cottrell RC; Gangolli SD
    Adv Exp Med Biol; 1981; 136 Pt B():1143-7. PubMed ID: 6283820
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of mutagenicity of diphenylhydantoin in in vitro short-term tests.
    Léonard A; de Meester C; Fabry L; de Saint-Georges L; Dumont P
    Mutat Res; 1984; 137(2-3):79-88. PubMed ID: 6433192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate.
    Bodine AB; Luer CA; Gangjee S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):255-7. PubMed ID: 2866897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of 3a,8a-dihydrofuro[2,3-b]benzofuran, a model of aflatoxin B1, for Salmonella typhimurium TA100.
    Coles BF; Smith JR; Garner RC
    Biochem Biophys Res Commun; 1977 Jun; 76(3):888-92. PubMed ID: 332158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.